文献速递临床试验与 GCP流行病学与生物统计真实世界研究与卫生经济

促进慢性病药物报销地方政府政策的采纳(PAPMed):中国南通农村一项实地整群随机试验的研究方案

Promoting the adoption of local governmental policy on the reimbursement of chronic disease medicines (PAPMed): study protocol of a field-based cluster randomized trial in rural Nantong, China.
PubMed 文献 · Trials · 2022-09-15

本研究针对中国南通农村非传染性疾病患者,基于行为科学理论设计干预方案,通过6个月整群随机对照试验在通州区两个乡镇的30个村中按1:1随机分为干预组与常规做法对照组,由村医接受培训、宣传政策并随访患者,主要结局为政策登记率,次要结局包括登记患者数、节省的医疗费用、村医访视频率和血压血糖等健康指标。

要点

  • 干预组村医接受政策细节、登记流程和干预方案的系统培训,并宣传政策鼓励登记。
  • 干预组村医在干预后第1、3、6个月随访患者,并根据绩效获得经济激励。
  • 主要结局为政策登记率,次要结局包括登记患者数、节省的医疗费用、村医访视频率和血压血糖水平。

核心结论

  • 本研究旨在开发基于行为科学的干预方案以促进慢性病药物报销政策的采纳,并评估其与常规做法相比的有效性。

研究设计与样本

  • 研究在中国南通通州区两个乡镇的30个村中开展6个月整群随机对照试验,按1:1比例随机分为干预组和对照组(常规做法)。

主要发现

  • 原文为研究方案,未报告试验结果。

关键数值与推荐

  • 主要结局为政策登记率;次要结局包括登记患者数、节省的医疗费用、村医访视频率以及血压和血糖水平等健康指标。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Among rural Chinese patients with non-communicable diseases (NCDs), low socioeconomic status increases the risk of developing NCDs and associated financial burdens in paying for medicines and treatments. Despite the chronic disease medicine reimbursement policy of the local government in Nantong City, China, various barriers prevent patients from registering for and benefitting from the policy. This study aims to develop a behavior science-based intervention program for promoting the adoption of the policy and to evaluate the effectiveness of the program compared with usual practices. METHODS: Barriers and opportunities affecting stakeholders in adopting the policy were identified through contextual research and summarized through behavior mapping. The intervention is designed to target these barriers and opportunities through behavior science theories and will be evaluated through a 6-month cluster randomized controlled trial in Tongzhou District, Nantong, China. A total of 30 villages from two townships are randomized in a 1:1 ratio to either the intervention or the control arm (usual practices). Village doctors in the intervention arm (1) receive systematic training on policy details, registration procedures, and intervention protocol, (2) promote the policy and encourage registration, (3) follow up with patients in the first, third, and sixth months after the intervention, and (4) receive financial incentives based on performance. The primary outcome is policy registration rate and the secondary outcomes include the number of patients registering for the policy, medical costs saved, frequency of village doctor visits, and health measures such as blood pressure and glucose levels. DISCUSSION: This study is one of very few that aims to promote adoption of NCDs outpatient medication reimbursement policies, and the first study to evaluate the impact of these policies on patients' financial and physical wellbeing in China. The simple, feasible, and scalable intervention is designed based on the theories of behavior science and is applicable to similar low-income regions nationwide where outpatient medical costs remain a financial burden for patients. TRIAL REGISTRATION: ClinicalTrials.gov NCT04731194 , registered on 29 January 2021; Chinese Clinical Trial Registry ChiCTR2100042152 , registered on 14 January 14 2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. He Z, Cao X, Zhao D, et al. Promoting the adoption of local governmental policy on the reimbursement of chronic disease medicines (PAPMed): study protocol of a field-based cluster randomized trial in rural Nantong, China. Trials. 2022. PMID: 36109757. doi:10.1186/s13063-022-06710-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。